LaserSight moves to Nasdaq SmallCap:
This article was originally published in Clinica
Executive Summary
Laser vision correction company LaserSight is no longer eligible for trading on the Nasdaq National Market and its stock was transferred to the Nasdaq SmallCap Market from August 9. Continued listing on the SmallCap requires that the company's shares close at $1 on or before August 13. It may, however, be eligible for a 180-day grace period if it can demonstrate shareholders' equity of at least $5m, is in compliance with all other requirements and files an application for a new listing and related review. The Winter Park, Florida-based company believes it meets the requirements and intends to file the application on time.